HIGHLIGHTS
- who: Lisa F. Amann and colleagues from the Department of Clinical Pharmacy, Institute of Pharmacy, University of Hamburg, Hamburg, Germany have published the article: Tigecycline Dosing Strategies in Critically Ill Liver-Impaired Patients, in the Journal: Antibiotics 2022, 11, 479. of 27/09/2013
- what: This study investigated tigecycline exposure in critically ill patients from a population pharmacokinetic perspective to support rational dosing in intensive care unit (ICU) patients with acute and chronic liver impairment. This study aimed to assess the iseffects of different covariates on tigecycline cannot be solely determined by a single endogenous . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.